Baxa Corporation Releases Abacus™ v2 Order Entry and Calculation Software for TPN

August 09, 2006 (PRLEAP.COM) Health News
Englewood, Colo. – Baxa Corporation announces the release of version two of its Abacus TPN Calculation Software. Abacus v2 is a Windows®-based software application used for total parenteral nutrition (TPN) order entry and compounding. Designed by health-system pharmacists, the software ensures safety and reduces the opportunity for user error in the prescribing, calculating and mixing of multi-source compounds.

“This new version of Abacus has significant advantages over the previous release,” affirms product manager Tim Kingsford, “It includes improved functionality over the previous release and addresses customer needs to ensure that Abacus is the safest tool available for pharmacy compounding.”

Abacus is the only Windows-based software application designed for safe pharmacy compounding for TPN products. Versions are offered to support stand-alone compounding for calculation without an automated compounder, single-workstation for driving one compounder and multi-workstation for order entry from multiple locations within a single facility. The Abacus Suite of products provides built-in safety features such as barcode generation, and user customization for warning limits, ordering templates and security. A graphical user interface and drop-down menus make Abacus easy-to-use and facilitate pharmacy staff training.

Baxa Corporation provides industry-leading software to complement its line of automation designed to streamline pharmacy fluid handling, syringe filling and automated compounding. Its Exacta-Mix™ 2400 and 600 Compounders are the state-of-the-art for automating multi-source compounding of sterile parenteral solutions.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com.

###

Contacts:

Marian Robinson, Vice President, Marketing
Baxa Corporation http://www.baxa.com 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR
Absolutely Public Relations http://www.absolutelypr.com 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com